# Patient Reported Outcomes and Patient Voice Among Patients Diagnosed With Low Risk Myelodysplastic Syndrome (LR-MDS) or Unexplained Anemia In Japan

> **NCT07008820** · — · RECRUITING · sponsor: **Bristol-Myers Squibb** · enrollment: 50 (estimated)

## Conditions studied

- Myelodysplastic Syndrome (MDS)

## Interventions

- **OTHER:** Health-related quality of life questionnaires
- **OTHER:** Qualitative interviews

## Key facts

- **NCT ID:** NCT07008820
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-13
- **Primary completion:** 2026-02-28
- **Final completion:** 2026-02-28
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07008820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07008820, "Patient Reported Outcomes and Patient Voice Among Patients Diagnosed With Low Risk Myelodysplastic Syndrome (LR-MDS) or Unexplained Anemia In Japan". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07008820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*